Fredrik Lehmann

Venture Partner

Joined: 2022

Involved in: AnaCardio, Guard Therapeutics

Interests: Diagnostics, HealthTech, MedTech, Therapeutics, Bio tech, Chemistry

Fredrik Lehmann

Fredrik focuses on life science, with an extra eye for innovative biotechs. He is interested in contributing to businesses with his experience from the biotech world to help companies reach their highest potential.

Fredrik has more than 20 years of experience from the life science industry;  as CEO, Head of Research and CMC in several companies. He has extensive experience from turning ideas into products and successful businesses, and have founded six companies, including OnTarget Chemistry that was acquired by Recipharm in 2015. He also serves as board director at several Life Sciences companies and is a member of the Scientific Advisory Board at Akthelia Pharmaceuticals.

Fredrik holds a PhD in medicinal chemistry from Gothenburg University and an MBA from Stockholm School of Economics.